Artesunate
- Generic Name
- Artesunate
- Brand Names
- Artesunate Amivas
- Drug Type
- Small Molecule
- Chemical Formula
- C19H28O8
- CAS Number
- 88495-63-0
- Unique Ingredient Identifier
- 60W3249T9M
- Background
Artesunate is indicated for the initial treatment of severe malaria. The World Health Organization recommends artesunate as first line treatment for severe malaria. Artesunate was developed out of a need for a more hydrophilic derivative of artemisinin.
Artesunate was granted FDA approval on 26 May 2020.
- Indication
Artesunate is indicated for the initial treatment of severe malaria in adult and pediatric patients.
- Associated Conditions
- Acute Uncomplicated Plasmodium Falciparum Malaria, Malaria, Cerebral, Severe Malaria
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath